Femme et Homme
- | Pays :
- Czech Republic
- Finland
- | Organes : -
- | Spécialités : -
Extrait
One year antibody persistence after the fourth dose boost or two catch-up doses administered starting from 12 months of age and to evaluate the response to a a third dose boost or two catch-up dose starting at 24 months of age.
Critère d'inclusion
- Meningococcal Disease